Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $906.38, with a 24-hour trading volume of $2.75B. The asset's market cap is $809.72B, after moving -1.89% in the last day.
Tokenized Eli Lilly And Co is trading at $910.93, with a tokenized market cap of $4.99M and a 24-hour trading volume of $2.25M. The tokenized asset has moved -2.52% in the past 24 hours.